RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer’s Disease
Recent Posts
Topcon Healthcare Expands Presence at ARVO 2026 with Record Research Activity
Topcon Healthcare announced a significant expansion of its scientific presence…
Read more
Topcon Healthcare Announces Leadership Appointments to Strengthen Americas Execution and Advance Global Eyecare Strategy
LA JOLLA, CA — Topcon Healthcare, Inc., a global leader in digital…
Read more
Topcon Healthcare, Inc. and RemoniHealth Announce a Commercial Partnership to Advance Remote Monitoring and Care Continuity for Chronic Eye Disease
LA JOLLA, CA — Topcon Healthcare, Inc., a global leader…
Read more